Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
05 December 2012Website:
http://www.biorestorative.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 28 Jun 2024 23:45:54 GMTDividend
Analysts recommendations
Institutional Ownership
BRTX Latest News
– Adds to comprehensive patent portfolio underlying novel ThermoStem ® technology platform –
- Brown adipose derived stem cells with brown adipogenic potential would represent a new modality for the treatment of obesity and related metabolic disorders –
Biorestorative Therapies, Inc. (BRTX) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to loss of $1.53 per share a year ago.
MELVILLE, NY., June 04, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, today announced that CEO Lance Alstodt will participate at the Jefferies Global Healthcare Conference being held June 5-6, 2024 at the Marriot Marquis in New York. Management will also be available for one-on-one investor meetings during the conference.
BioRestorative Therapies, Inc. (NASDAQ:BRTX) held its Q1 2024 Earnings Conference Call on May 14, 2024 at 4:30 PM ET. The call featured company representatives including Stephen Kilmer, Lance Alstodt, Robert Kristal, and Francisco Silva, along with conference call participants Michael Okunewitch and Jonathan Aschoff. Good afternoon, everyone, and welcome to the BioRestorative Therapies Q1 Business Update Conference Call. Participants are currently in a listen-only mode, and questions will be addressed following the presentation.
On July 25, 2023, Lance Alstodt, President, CEO, COB, and 10% Owner of BioRestorative Therapies Inc ( BRTX , Financial), made a significant purchase of 4200 shares of the company's stock. This move is noteworthy as insider buying can often be a positive indicator for the company's future performance.
What type of business is BioRestorative Therapies?
BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. was incorporated in 1997 and is based in Melville, New York.
What sector is BioRestorative Therapies in?
BioRestorative Therapies is in the Healthcare sector
What industry is BioRestorative Therapies in?
BioRestorative Therapies is in the Biotechnology industry
What country is BioRestorative Therapies from?
BioRestorative Therapies is headquartered in United States
When did BioRestorative Therapies go public?
BioRestorative Therapies initial public offering (IPO) was on 05 December 2012
What is BioRestorative Therapies website?
https://www.biorestorative.com
Is BioRestorative Therapies in the S&P 500?
No, BioRestorative Therapies is not included in the S&P 500 index
Is BioRestorative Therapies in the NASDAQ 100?
No, BioRestorative Therapies is not included in the NASDAQ 100 index
Is BioRestorative Therapies in the Dow Jones?
No, BioRestorative Therapies is not included in the Dow Jones index
When does BioRestorative Therapies report earnings?
Next earnings report date is not announced yet